Citation: Hs. Yoon et al., Transformation of kidney epithelial cells by a quinol thioether via inactivation of the tuberous sclerosis-2 tumor suppressor gene, MOL CARCINO, 31(1), 2001, pp. 37-45
Authors:
Lau, SS
Monks, TJ
Everitt, JI
Kleymenova, E
Walker, CL
Citation: Ss. Lau et al., Carcinogenicity of a nephrotoxic metabolite of the "nongenotoxic" carcinogen hydroquinone, CHEM RES T, 14(1), 2001, pp. 25-33
Citation: E. Kleymenova et Cl. Walker, Determination of loss of heterozygosity in frozen and paraffin embedded tumors by denaturating high-performance liquid chromatography (DHPLC), J BIOCH BIO, 47(1-2), 2001, pp. 83-90
Authors:
Monsfield, AM
Marshall, M
Walker, CL
Hubbard, P
Citation: Am. Monsfield et al., Physical and chemical evidence remaining after the explosion of large improvised bombs. Part 3. Firings of calcium carbonate ammonium Nitrate/Sugar, J FOREN SCI, 46(3), 2001, pp. 535-548
Citation: Md. Coleman et Cl. Walker, Effects of oxidised alpha-lipoic acid and alpha-tocopherol on xenobiotic-mediated methaemoglobin formation in diabetic and non-diabetic human erythrocytes in-vitro, ENV TOX PH, 8(2), 2000, pp. 127-132
Citation: Ad. Perera et al., Requirement for the von Hippel-Lindau tumor suppressor gene for functionalepidermal growth factor receptor blockade by monoclonal antibody C225 in renal cell carcinoma, CLIN CANC R, 6(4), 2000, pp. 1518-1523
Authors:
Walker, CL
Burroughs, KD
Davis, B
Sowell, K
Everitt, JI
Fuchs-Young, R
Citation: Cl. Walker et al., Preclinical evidence for therapeutic efficacy of selective estrogen receptor modulators for uterine leiomyoma, J SOC GYN I, 7(4), 2000, pp. 249-256
Authors:
Kleymenova, E
Muga, S
Fischer, S
Walker, CL
Citation: E. Kleymenova et al., Application of high-performance liquid chromatography-based analysis of DNA fragments to molecular carcinogenesis, MOL CARCINO, 29(2), 2000, pp. 51-58
Citation: K. Cesen-cummings et al., Lessons from pregnancy and parturition: uterine leiomyomas result front discordant differentiation and dedifferentiation responses in smooth muscle cells, MED HYPOTH, 55(6), 2000, pp. 485-490
Citation: Ds. Hunter et al., Influence of exogenous estrogen receptor ligands on uterine leiomyoma: Evidence from an in vitro/in vivo animal model for uterine fibroids, ENVIR H PER, 108, 2000, pp. 829-834
Authors:
Gamage, SD
Bischoff, ED
Burroughs, KD
Lamph, WW
Gottardis, MM
Walker, CL
Fuchs-Young, R
Citation: Sd. Gamage et al., Efficacy of LGD1069 (targretin), a retinoid X receptor-selective ligand, for treatment of uterine leiomyoma, J PHARM EXP, 295(2), 2000, pp. 677-681
Authors:
Burroughs, KD
Fuchs-Young, R
Davis, B
Walker, CL
Citation: Kd. Burroughs et al., Altered hormonal responsiveness of proliferation and apoptosis during myometrial maturation and the development of uterine leiomyomas in the rat, BIOL REPROD, 63(5), 2000, pp. 1322-1330
Citation: Ev. Kleymenova et al., Genetic variants of the tuberous sclerosis 2 tumour suppressor gene in mouse t haplotypes, GENET RES, 74(2), 1999, pp. 139-144
Authors:
Hunter, DS
Hodges, LC
Vonier, PM
Fuchs-Young, R
Gottardis, MM
Walker, CL
Citation: Ds. Hunter et al., Estrogen receptor activation via activation function 2 predicts agonism ofxenoestrogens in normal and neoplastic cells of the uterine myometrium, CANCER RES, 59(13), 1999, pp. 3090-3099
Authors:
Tang, T
Owen, JD
Du, JG
Walker, CL
Richmond, A
Citation: T. Tang et al., Molecular cloning and characterization of a mouse gene with homology to the Duffy-antigen receptor for chemokines, DNA SEQ, 9(3), 1998, pp. 129-143
Authors:
Rennebeck, G
Kleymenova, EV
Anderson, R
Yeung, RS
Artzt, K
Walker, CL
Citation: G. Rennebeck et al., Loss of function of the tuberous sclerosis 2 tumor suppressor gene resultsin embryonic lethality characterized by disrupted neuroepithelial growth and development, P NAS US, 95(26), 1998, pp. 15629-15634